The types of tests used to monitor health can be expensive. Alternative ways of assessing patient health and making decisions about treatment and care are an important aspect of health care in resource-limited settings. This can include taking a detailed patient history and performing a physical examination.

Health monitoring in resource-limited settings: latest news

Health monitoring in resource-limited settings resources

Health monitoring in resource-limited settings features

Health monitoring in resource-limited settings news from aidsmap

More news

Health monitoring in resource-limited settings news selected from other sources

  • Abbott gets WHO prequalification for point-of-care HIV test

    The World Health Organization has granted prequalification to Abbot's point-of-care test of HIV viral load. WHO's action confirms the diagnostic, m-PIMA HIV-1/2 VL, meets its quality, safety and efficacy standards, potentially giving ministries of health and other funders the confidence to buy the test. Abbott said the diagnostic can expand access to viral load testing in resource-limited settings and, by extension, improve management of HIV.

    12 May 2019 | Med Tech Drive
  • Confidentiality breaches, stigma and a lack of time are stopping men in Côte d’Ivoire from getting tested and treated for HIV

    Interviews with men in Côte d’Ivoire reveal radical differences in the perceptions of those who do and don’t access care. Research, published in PLOS ONE, found many of the worries of men out of care are not reflected in the experiences of those with regular contact with services. Men’s perceptions were linked with their level of engagement with HIV care, with men who have regular contact with HIV testing and treatment services displaying more positive attitudes than those with little or no contact with such services. The paper can be seen at https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211385

    24 April 2019 | AVERT
  • Xpert testing to find TB in people with advanced HIV at diagnosis saves lives, study finds

    A study reported in Clinical Infectious Diseases this week confirms that patients newly diagnosed with HIV who were screened for TB with Xpert technology had higher survival rates in the year that followed than those screened with a point-of-care test using flourescent light-emitting microscopy.

    08 April 2019 | Science Speaks
  • Viral load monitoring motivates HIV treatment adherence in eSwatini

    The treat-all policy will only succeed if people keep taking their HIV treatment. It is important to motivate people who started treatment while they were still feeling well. 

    24 February 2019 | AVERT
  • Back to the future with CD4 testing: Improving HIV care in low- and middle-income countries

    A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of lives, according to an Essay published January 15 in the open-access journal PLOS Medicine by Mark Tenforde of the University of Washington School of Medicine, and colleagues.

    16 January 2019 | Science Daily
  • Access to on-the-spot testing led to improved rates of treatment for infants with HIV

    Tests to detect HIV in infants conducted at health facilities where they received care led to a significant increase in the percentage of infants with the virus given access to life-saving treatment, compared to tests analyzed in central laboratories, according to a report in Clinical Infectious Diseases.

    22 August 2018 | Science Speaks
  • Price Of HIV Viral Load Test Falls, Raising Hopes In Global AIDS Fight

    The Clinton Health Access Initiative, along with several other development agencies, has brokered an agreement to make routine HIV tests more accessible. They're aiming to make HIV viral load tests available for $12 a piece, slashing the price in some markets by more than 50 percent.

    02 August 2018 | NPR
  • Hologic's Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries

    Hologic, Inc. announced today the launch of the new Hologic Global Access Initiative, in partnership with the Clinton Health Access Initiative (CHAI) and MedAccess (backed by the U.K. government), to increase affordable access to molecular testing for HIV, hepatitis B and C (HBV and HCV) and human papillomavirus (HPV) in nearly 50 nations around the world. These countries, primarily across Africa and Southeast Asia, make up 90 percent of the HIV disease burden globally.

    25 July 2018 | Hologic press release
  • Commentary on U=U campaign - Follow Up on previous article 'On Fear, Infectiousness and Undetectability'

    Last week, GNP+ published a statement offering an alternative perspective on the messaging of campaigns on the uninfectiousness of people living with HIV who achieve viral suppression, including the U=U (Undetectable = Untransmittable) campaign. Following reactions from supporters of the campaign, GNP+ releases the following statement clarifying our position on this important issue.

    15 February 2017 | GNPPlus
  • HIV viral load testing capacities progress, require global support, multiple partners to reach 90-90-90 goals

    Four of seven sub-Saharan African countries followed by researchers over the last year and a half now can track the effectiveness of HIV treatment among all patients receiving it with tests to measure the levels of virus in their bodies at least once a year, according to an update in last week’s Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

    06 December 2016 | Science Speaks
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.